DK1267924T3 - Immunterapeutiske metoder og sammensætninger - Google Patents

Immunterapeutiske metoder og sammensætninger

Info

Publication number: DK1267924T3
Authority: DK; Denmark
Prior art keywords: antigen presenting; presenting cells; compositions; relates; immunotherapeutic methods
Prior art date: 2000-03-24

Application number

DK01929778.7T

Other languages

English (en)

Inventor

James Dobbie

Original Assignee

Lamellar Biomedical Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-24

Filing date

2001-03-26

Publication date

2012-05-29

2001-03-26 Application filed by Lamellar Biomedical Ltd filed Critical Lamellar Biomedical Ltd

2012-05-29 Application granted granted Critical

2012-05-29 Publication of DK1267924T3 publication Critical patent/DK1267924T3/da

Links

238000000034 method Methods 0.000 title abstract 2
239000000203 mixture Substances 0.000 title abstract 2
230000001024 immunotherapeutic effect Effects 0.000 title 1
210000000612 antigen-presenting cell Anatomy 0.000 abstract 3
102000004196 processed proteins & peptides Human genes 0.000 abstract 2
108090000765 processed proteins & peptides Proteins 0.000 abstract 2
239000002671 adjuvant Substances 0.000 abstract 1
239000000427 antigen Substances 0.000 abstract 1
102000036639 antigens Human genes 0.000 abstract 1
108091007433 antigens Proteins 0.000 abstract 1
210000004027 cell Anatomy 0.000 abstract 1
150000005829 chemical entities Chemical class 0.000 abstract 1
210000000987 immune system Anatomy 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
150000003904 phospholipids Chemical class 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dispersion Chemistry (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Tropical Medicine & Parasitology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

DK01929778.7T 2000-03-24 2001-03-26 Immunterapeutiske metoder og sammensætninger DK1267924T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0007150.6A GB0007150D0 (en)	2000-03-24	2000-03-24	Immunotherapeutic methods and compositions
PCT/GB2001/001936 WO2001072277A2 (en)	2000-03-24	2001-03-26	Immunotherapeutic methods and compositions

Publications (1)

Publication Number	Publication Date
DK1267924T3 true DK1267924T3 (da)	2012-05-29

Family

ID=9888324

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01929778.7T DK1267924T3 (da)	2000-03-24	2001-03-26	Immunterapeutiske metoder og sammensætninger

Country Status (13)

Country	Link
US (2)	US20040110695A1 (da)
EP (1)	EP1267924B1 (da)
JP (1)	JP2004517031A (da)
AT (1)	ATE544470T1 (da)
AU (2)	AU5646101A (da)
CA (1)	CA2404325C (da)
DK (1)	DK1267924T3 (da)
ES (1)	ES2382070T3 (da)
GB (1)	GB0007150D0 (da)
NO (1)	NO333157B1 (da)
NZ (1)	NZ522058A (da)
PT (1)	PT1267924E (da)
WO (1)	WO2001072277A2 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0007150D0 (en) *	2000-03-24	2000-05-17	Lamellar Therapeutics Limited	Immunotherapeutic methods and compositions
GB0207653D0 (en) *	2002-04-03	2002-05-15	Lamellar Therapeutics Ltd	Methods of using lamellar bodies for therapeutic purposes
KR101192652B1 (ko) *	2003-02-06	2012-10-19	앤저 테라퓨틱스 인코퍼레이티드	비포식 세포로의 침투가 약화된 리스테리아, 리스테리아를 포함하는 백신, 및 그것의 사용방법
US11324698B2 (en) *	2003-08-28	2022-05-10	Vgsk Technologies, Inc.	Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating the respiratory tract of a mammal
GB0322448D0 (en) *	2003-09-25	2003-10-29	Lamellar Therapeutics Ltd	Using lamellar bodies to modify linear biological macro molecules
AU2004275550B2 (en) *	2003-09-25	2011-08-18	Lamellar Biomedical Limited	Compositions and methods of using lamellar bodies for therapeutic purposes
CA2572985C (en) *	2004-07-07	2014-04-22	Statens Serum Institut	Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids
US20070299431A1 (en)	2006-05-02	2007-12-27	Green Medical, Inc.	Systems and methods for treating superficial venous malformations like spider veins
US7465312B2 (en)	2006-05-02	2008-12-16	Green Medical, Inc.	Systems and methods for treating superficial venous malformations like spider veins
JP5667180B2 (ja) *	2009-07-01	2015-02-12	イオンメディックスインコーポレイテッド	哺乳類の有核細胞に由来するマイクロベシクル及びその用途
KR101232377B1 (ko)	2010-07-01	2013-02-13	주식회사이언메딕스	세포의 원형질체에서 유래한 마이크로베시클 및 이의 용도
DK2714017T3 (da) *	2011-06-02	2018-09-03	Univ California	Membran-indkapslede nanopartikler og fremgangsmåde til anvendelse
WO2015021390A2 (en)	2013-08-08	2015-02-12	The Regents Of The University Of California	Nanoparticles leverage biological membranes to target pathogens for disease treatment and diagnosis
US20170000875A1 (en)	2013-12-02	2017-01-05	Arytha Biosciences, Llc	Toxoid preparation and uses thereof
CN106163504B (zh)	2014-03-20	2021-02-09	加利福尼亚大学董事会	水凝胶毒素-吸收或结合纳米颗粒
WO2015187502A1 (en)	2014-06-02	2015-12-10	Cellics Therapeutics, Inc.	Use of nanoparticles coated with red blood cell membranes to treat hemolytic diseases and disorders
WO2016109306A1 (en)	2015-01-02	2016-07-07	Cellics Therapeutics, Inc.	Use of nanoparticles coated with red blood cell membranes to enable blood transfusion
US10610493B2 (en)	2015-04-29	2020-04-07	The Regents Of The University Of California	Detoxification using nanoparticles
CA2997286A1 (en)	2015-09-14	2017-03-23	Vgsk Technologies, Inc.	A sterically stabilized carrier for subcutaneous, sublingual and oral therapeutics, compositions and methods for treating a mammal
EP3632410A1 (en)	2018-10-05	2020-04-08	Lamellar Biomedical Limited	Lipidic polynucleotide carriers for cellular delivery
EP3692984A1 (en)	2019-02-08	2020-08-12	Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts	Annexin-coated particles

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5925375A (en) *	1987-05-22	1999-07-20	The Liposome Company, Inc.	Therapeutic use of multilamellar liposomal prostaglandin formulations
US5403592A (en) *	1987-08-25	1995-04-04	Macnaught Pty Limited	Lubricant composition for rheumatism
US5006343A (en) *	1988-12-29	1991-04-09	Benson Bradley J	Pulmonary administration of pharmaceutically active substances
FR2645878B1 (fr) *	1989-04-17	1994-02-25	Institut Nal Sante Recherc Medic	Sequences nucleotidiques d'actinomycetales, applications a la synthese ou a la detection d'acides nucleiques, produits d'expression de ces sequences et application en tant que compositions immunogenes
US5088499A (en) *	1989-12-22	1992-02-18	Unger Evan C	Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
WO1992021981A1 (en) *	1991-05-29	1992-12-10	Baxter International Inc.	Methods and compositions for the prevention, diagnosis, and treatment of inflammatory serosal disease and related conditions
JPH05339169A (ja) *	1992-03-03	1993-12-21	Dai Ichi Seiyaku Co Ltd	経口ワクチン
WO1997003703A1 (en) *	1995-07-21	1997-02-06	Rhone-Poulenc Rorer Pharmaceuticals Inc.	Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity
US5543152A (en) *	1994-06-20	1996-08-06	Inex Pharmaceuticals Corporation	Sphingosomes for enhanced drug delivery
US5462752A (en) *	1994-07-28	1995-10-31	Prp, Inc.	Inhibition of platelet binding
US5643599A (en) *	1995-06-07	1997-07-01	President And Fellows Of Harvard College	Intracellular delivery of macromolecules
AU727863B2 (en) *	1997-05-08	2001-01-04	Oncothyreon Inc.	Method for generating activated T-cells and antigen-pulsed antigen-presenting cells
GB9807298D0 (en) *	1998-04-03	1998-06-03	Britannia Pharmaceuticals Ltd	Medicament
EP0976403A1 (en) *	1998-07-30	2000-02-02	Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO)	Adjuvant comprising pulmonary surfactant
US6290987B1 (en) *	1998-09-27	2001-09-18	Generex Pharmaceuticals, Inc.	Mixed liposome pharmaceutical formulation with amphiphiles and phospholipids
US6193997B1 (en) *	1998-09-27	2001-02-27	Generex Pharmaceuticals Inc.	Proteinic drug delivery system using membrane mimetics
GB0007150D0 (en) *	2000-03-24	2000-05-17	Lamellar Therapeutics Limited	Immunotherapeutic methods and compositions
GB0207653D0 (en) *	2002-04-03	2002-05-15	Lamellar Therapeutics Ltd	Methods of using lamellar bodies for therapeutic purposes
GB0322448D0 (en) *	2003-09-25	2003-10-29	Lamellar Therapeutics Ltd	Using lamellar bodies to modify linear biological macro molecules

2000
- 2000-03-24 GB GBGB0007150.6A patent/GB0007150D0/en not_active Ceased
2001
- 2001-03-26 DK DK01929778.7T patent/DK1267924T3/da active
- 2001-03-26 ES ES01929778T patent/ES2382070T3/es not_active Expired - Lifetime
- 2001-03-26 NZ NZ522058A patent/NZ522058A/en not_active IP Right Cessation
- 2001-03-26 AT AT01929778T patent/ATE544470T1/de active
- 2001-03-26 PT PT01929778T patent/PT1267924E/pt unknown
- 2001-03-26 JP JP2001570238A patent/JP2004517031A/ja active Pending
- 2001-03-26 CA CA2404325A patent/CA2404325C/en not_active Expired - Lifetime
- 2001-03-26 AU AU5646101A patent/AU5646101A/xx active Pending
- 2001-03-26 US US10/239,576 patent/US20040110695A1/en not_active Abandoned
- 2001-03-26 WO PCT/GB2001/001936 patent/WO2001072277A2/en active IP Right Grant
- 2001-03-26 EP EP01929778A patent/EP1267924B1/en not_active Expired - Lifetime
- 2001-03-26 AU AU2001256461A patent/AU2001256461B2/en not_active Ceased
2002
- 2002-09-24 NO NO20024571A patent/NO333157B1/no not_active IP Right Cessation
2006
- 2006-07-24 US US11/491,177 patent/US20080069866A1/en not_active Abandoned

Also Published As

Publication number	Publication date
JP2004517031A (ja)	2004-06-10
AU2001256461B2 (en)	2005-06-30
ATE544470T1 (de)	2012-02-15
EP1267924B1 (en)	2012-02-08
GB0007150D0 (en)	2000-05-17
NZ522058A (en)	2005-05-27
NO20024571D0 (no)	2002-09-24
NO20024571L (no)	2002-10-14
US20040110695A1 (en)	2004-06-10
ES2382070T3 (es)	2012-06-05
US20080069866A1 (en)	2008-03-20
EP1267924A2 (en)	2003-01-02
AU5646101A (en)	2001-10-08
WO2001072277A2 (en)	2001-10-04
PT1267924E (pt)	2012-05-24
CA2404325C (en)	2012-06-12
NO333157B1 (no)	2013-03-18
CA2404325A1 (en)	2001-10-04
WO2001072277A3 (en)	2002-06-13

Publication	Publication Date	Title
DK1267924T3 (da)	2012-05-29	Immunterapeutiske metoder og sammensætninger
PT2351579T (pt)	2016-12-22	Vacinas polipeptídicas para proteção ampla contra linhagens meningocócicas hipervirulentas
NZ331651A (en)	2000-01-28	BSW17 peptide immunogens for vaccination against and treatment of allergy
IS4518A (is)	1999-01-10	Nýtt lyfjaform fyrir bóluefni
AU6632496A (en)	1997-03-05	Cell derived antigen presenting vesicles
NO973250L (no)	1997-09-05	Preparater for avlevering av antigener
WO2005037190A3 (en)	2005-12-29	Multiplex vaccines
EP0804158A4 (en)	1999-05-12	PREPARATIONS AND METHOD FOR TRIGGERING CTL IMMUNITY
TR200002930T2 (tr)	2000-12-21	Kolaylaştırıcı kompozisyonlar
DK1002110T3 (da)	2003-05-26	Immunsvar mod HPV-antigener fremkaldt af sammensætninger, som omfatter et HPV-antigen og et stressprotein eller en ekspressionsvektor i stand til at ekspressere disse proteiner
DK0900380T3 (da)	2003-11-03	Fremgangsmåde til udvælgelse og fremstilling af T-celle-peptid-epitoper og vacciner indeholdende disse udvalgte epitoper
GB0130123D0 (en)	2002-02-06	Outer membrane vesicle vaccine and its preparation
AU3847801A (en)	2001-08-27	Proteosome influenza vaccine
OA09800A (en)	1994-04-15	Vaccine compositions containing liposomes.
GR3017778T3 (en)	1996-01-31	Immunogenic complexes, in particular iscoms.
ES2177927T3 (es)	2002-12-16	Composicion para provocar una reaccion inmunologica a un determinante antigenico no proteinico.
AU1800597A (en)	1997-08-28	Novel methods of vaccination and vaccines therefore comprising a nucleic acid encoding a first epitope and a peptide containing a second epitope
AU2002309259A1 (en)	2003-11-11	Improved polysaccharide and glycoconjugate vaccines_____________
ATE419870T1 (de)	2009-01-15	Neuer immunogener komplex
WO2004030616A3 (en)	2004-10-07	Ii-KEY/ANTIGENIC EPITOPE HYBRID PEPTIDE VACCINES
AU6078399A (en)	2000-04-17	Ligand presenting assembly (lpa), method of preparation and uses thereof
WO2004033483A3 (en)	2005-06-09	Liposomal system and method of using same
DK0952771T3 (da)	2008-05-19	Hidtil ukendte saponinpræparater og anvendelser deraf
WO1999047102A3 (en)	1999-10-21	Methods for enhanced antigen presentation on antigen-presenting cells and compositions produced thereby
BR9905780A (pt)	2001-04-24	Antìgenos vacinais de leptospira para prevenção da laptospirose